• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无规则区域的突变可以通过形成双亮氨酸基序导致疾病。

Mutations in Disordered Regions Can Cause Disease by Creating Dileucine Motifs.

机构信息

Proteome Dynamics, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Str. 10, 13125 Berlin, Germany.

Bioinformatics Platform, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Str. 10, 13125 Berlin, Germany.

出版信息

Cell. 2018 Sep 20;175(1):239-253.e17. doi: 10.1016/j.cell.2018.08.019. Epub 2018 Sep 6.

DOI:10.1016/j.cell.2018.08.019
PMID:30197081
Abstract

Many disease-causing missense mutations affect intrinsically disordered regions (IDRs) of proteins, but the molecular mechanism of their pathogenicity is enigmatic. Here, we employ a peptide-based proteomic screen to investigate the impact of mutations in IDRs on protein-protein interactions. We find that mutations in disordered cytosolic regions of three transmembrane proteins (GLUT1, ITPR1, and CACNA1H) lead to an increased clathrin binding. All three mutations create dileucine motifs known to mediate clathrin-dependent trafficking. Follow-up experiments on GLUT1 (SLC2A1), the glucose transporter causative of GLUT1 deficiency syndrome, revealed that the mutated protein mislocalizes to intracellular compartments. Mutant GLUT1 interacts with adaptor proteins (APs) in vitro, and knocking down AP-2 reverts the cellular mislocalization and restores glucose transport. A systematic analysis of other known disease-causing variants revealed a significant and specific overrepresentation of gained dileucine motifs in structurally disordered cytosolic domains of transmembrane proteins. Thus, several mutations in disordered regions appear to cause "dileucineopathies."

摘要

许多致病的错义突变影响蛋白质的无规则区域(IDR),但其致病的分子机制尚不清楚。在这里,我们采用基于肽的蛋白质组学筛选来研究 IDR 中突变对蛋白质-蛋白质相互作用的影响。我们发现,三种跨膜蛋白(GLUT1、ITPR1 和 CACNA1H)无规则胞质区域的突变导致网格蛋白结合增加。所有三种突变都产生了介导网格蛋白依赖性运输的二亮氨酸基序。对葡萄糖转运蛋白 GLUT1(SLC2A1)的后续实验,即导致 GLUT1 缺乏综合征的葡萄糖转运蛋白,表明突变蛋白错误定位到细胞内隔室。突变 GLUT1 在体外与衔接蛋白(AP)相互作用,敲低 AP-2 可恢复细胞内定位并恢复葡萄糖转运。对其他已知致病变体的系统分析表明,在跨膜蛋白的结构无序胞质结构域中,获得的二亮氨酸基序明显且特异性过表达。因此,无序区域的几种突变似乎导致了“二亮氨酸病”。

相似文献

1
Mutations in Disordered Regions Can Cause Disease by Creating Dileucine Motifs.无规则区域的突变可以通过形成双亮氨酸基序导致疾病。
Cell. 2018 Sep 20;175(1):239-253.e17. doi: 10.1016/j.cell.2018.08.019. Epub 2018 Sep 6.
2
Mechanistic Insights into Protein Stability and Self-aggregation in GLUT1 Genetic Variants Causing GLUT1-Deficiency Syndrome.GLUT1 缺乏综合征相关 GLUT1 基因突变导致的蛋白稳定性和自身聚集的机制研究
J Membr Biol. 2020 Apr;253(2):87-99. doi: 10.1007/s00232-020-00108-3. Epub 2020 Feb 5.
3
Absence of SLC2A1 mutations does not exclude Glut1 deficiency syndrome.SLC2A1 基因突变的缺失并不排除 Glut1 缺乏综合征。
Neuropediatrics. 2013 Aug;44(4):235-6. doi: 10.1055/s-0033-1336015. Epub 2013 Mar 12.
4
The role of SLC2A1 mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndrome.SLC2A1突变在肌阵挛失张力癫痫和失神癫痫中的作用,以及GLUT1缺乏综合征的估计发病率。
Epilepsia. 2015 Dec;56(12):e203-8. doi: 10.1111/epi.13222. Epub 2015 Nov 5.
5
A Protein Kinase C Phosphorylation Motif in GLUT1 Affects Glucose Transport and is Mutated in GLUT1 Deficiency Syndrome.葡萄糖转运蛋白1(GLUT1)中的蛋白激酶C磷酸化基序影响葡萄糖转运,且在GLUT1缺陷综合征中发生突变。
Mol Cell. 2015 Jun 4;58(5):845-53. doi: 10.1016/j.molcel.2015.04.015. Epub 2015 May 14.
6
Dileucine-based sorting signals bind to the beta chain of AP-1 at a site distinct and regulated differently from the tyrosine-based motif-binding site.基于双亮氨酸的分选信号在一个与基于酪氨酸的基序结合位点不同且调控方式也不同的位点与AP-1的β链结合。
EMBO J. 1998 Apr 15;17(8):2148-55. doi: 10.1093/emboj/17.8.2148.
7
Three novel SLC2A1 mutations in Bulgarian patients with different forms of genetic generalized epilepsy reflecting the clinical and genetic diversity of GLUT1-deficiency syndrome.三种新的 SLC2A1 突变在具有不同形式遗传性全面性癫痫的保加利亚患者中被发现,反映了 GLUT1 缺乏综合征的临床和遗传多样性。
Seizure. 2018 Jan;54:41-44. doi: 10.1016/j.seizure.2017.11.014. Epub 2017 Nov 28.
8
Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome.葡萄糖转运蛋白1(SLC2A1)缺陷综合征中GLUT1(SLC2A1)的突变分析。
Hum Mutat. 2000 Sep;16(3):224-31. doi: 10.1002/1098-1004(200009)16:3<224::AID-HUMU5>3.0.CO;2-P.
9
A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor.HIV-1 Nef中的双亮氨酸基序作为CD4下调的内化信号,并与AP-1网格蛋白衔接蛋白结合。
Curr Biol. 1998 Nov 5;8(22):1235-8. doi: 10.1016/s0960-9822(07)00517-9.
10
Upstream SLC2A1 translation initiation causes GLUT1 deficiency syndrome.上游SLC2A1翻译起始导致葡萄糖转运蛋白1缺乏综合征。
Eur J Hum Genet. 2017 Jun;25(6):771-774. doi: 10.1038/ejhg.2017.45. Epub 2017 Apr 5.

引用本文的文献

1
Glut1 Deficiency Syndrome: Novel Pathomechanisms, Current Concepts, and Challenges.葡萄糖转运蛋白1缺乏综合征:新的发病机制、当前概念及挑战
J Inherit Metab Dis. 2025 May;48(3):e70044. doi: 10.1002/jimd.70044.
2
Progress in Understanding the Regulation of Glucose and Fructose Metabolism.理解葡萄糖和果糖代谢调控的进展
Annu Rev Nutr. 2025 Apr 18. doi: 10.1146/annurev-nutr-111824-012939.
3
From morphology to single-cell molecules: high-resolution 3D histology in biomedicine.从形态学到单细胞分子:生物医学中的高分辨率三维组织学
Mol Cancer. 2025 Mar 3;24(1):63. doi: 10.1186/s12943-025-02240-x.
4
Single-point mutations in disordered proteins: Linking sequence, ensemble, and function.无序蛋白质中的单点突变:连接序列、整体结构与功能。
Curr Opin Struct Biol. 2025 Apr;91:102987. doi: 10.1016/j.sbi.2025.102987. Epub 2025 Feb 5.
5
Decoding the functional impact of the cancer genome through protein-protein interactions.通过蛋白质-蛋白质相互作用解码癌症基因组的功能影响。
Nat Rev Cancer. 2025 Mar;25(3):189-208. doi: 10.1038/s41568-024-00784-6. Epub 2025 Jan 14.
6
Accurate sequence-to-affinity models for SH2 domains from multi-round peptide binding assays coupled with free-energy regression.通过多轮肽结合试验结合自由能回归得到的SH2结构域的精确序列-亲和力模型。
bioRxiv. 2025 Jan 5:2024.12.23.630085. doi: 10.1101/2024.12.23.630085.
7
SPOT: spatial proteomics through on-site tissue-protein-labeling.SPOT:通过现场组织蛋白标记实现的空间蛋白质组学
Clin Proteomics. 2024 Oct 24;21(1):60. doi: 10.1186/s12014-024-09505-5.
8
Proteome-scale characterisation of motif-based interactome rewiring by disease mutations.基于模体的互作网络重排的疾病突变的蛋白质组尺度特征分析。
Mol Syst Biol. 2024 Sep;20(9):1025-1048. doi: 10.1038/s44320-024-00055-4. Epub 2024 Jul 15.
9
Pathogenic mutations of human phosphorylation sites affect protein-protein interactions.人类磷酸化位点的致病突变影响蛋白质-蛋白质相互作用。
Nat Commun. 2024 Apr 11;15(1):3146. doi: 10.1038/s41467-024-46794-8.
10
Human In Vitro Models of Neuroenergetics and Neurometabolic Disturbances: Current Advances and Clinical Perspectives.神经能量学和神经代谢紊乱的人体体外模型:当前进展和临床观点。
Stem Cells Transl Med. 2024 Jun 14;13(6):505-514. doi: 10.1093/stcltm/szae021.